Civica


Nonprofit organization founded by U.S. health systems to stabilize supply and reduce prices of essential generic medicines. Operates a U.S. manufacturing facility for sterile injectable generics, develops and sources essential medicines (including biosimilar insulin initiatives), and provides long-term contracting and distribution to hospitals and public stockpiles. Emphasizes domestic sourcing, multi-month inventory buffers, supplier quality oversight, and a consumer-access channel for affordable generics.

Industries

Pharmaceutical
Pharmaceutical Manufacturing

Nr. of Employees

medium (51-250)


Products

Vancomycin (sterile injectable)

Sterile injectable formulation of the generic antibiotic vancomycin distributed to member hospitals.

Naloxone (generic formulation)

Generic naloxone product for emergency treatment of opioid overdose.

Morphine (generic formulation)

Generic morphine product intended for hospital and acute care use.

Dexamethasone (generic formulation)

Generic corticosteroid product for clinical use.

Heparin (generic injectable)

Generic heparin injectable products for anticoagulation management.

Prochlorperazine (generic formulation)

Generic antiemetic/antipsychotic product for clinical use.

View All Products

Services

On-site manufacturing capacity and production services for sterile generic injectables and other essential medicines for health systems and institutional customers.

A consumer-facing channel to offer lower-cost generic medicines directly to patients.

Contracting and distribution services that provide multi-month supply commitments and single-price access for participating customers.

Expertise Areas

  • Generic sterile injectable manufacturing
  • Biosimilar insulin development and manufacturing
  • Essential medicines supply stabilization and contracting
  • Regulatory compliance and GxP quality systems
  • Show More (3)

Key Technologies

  • Aseptic vial filling and packaging
  • Isolator aseptic containment
  • Automated high-speed filling lines
  • Biosimilar (insulin) production platforms
  • Show More (3)

News & Updates

Organization established in 2018 by health systems to stabilize supply and lower costs of essential generic medicines.

Initial distribution of vancomycin to member hospitals, marking transition to in-market supply.

Provided 2.1 million vials to the U.S. Strategic National Stockpile during national pandemic response.

Construction of the Petersburg, Virginia essential medicines manufacturing facility commenced.

Named manufacturing partner for a biosimilar insulin initiative to expand affordable insulin access.

Installation of automated high-value filling lines to increase sterile injectable production capacity.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.